Evidence mapPaperPMID 29434812Full record

ArticleExperimental and therapeutic medicine2018

Combination therapeutic effects of high intensity focused ultrasound and Metformin for the treatment of adenomyosis.

Yanmei Hou, Zhenli Qin, Kefeng Fan, Yanhua Xu, Xiaoge Huang

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yanmei HouDepartment of Gynaecology and Obstetrics, Jinan Maternity and Child Care Hospital, Shizhong, Jinan 250001, P.R. China.
Zhenli QinDepartment of Gynaecology and Obstetrics, Jinan Maternity and Child Care Hospital, Shizhong, Jinan 250001, P.R. China.
Kefeng FanDepartment of Gynaecology and Obstetrics, Jinan Maternity and Child Care Hospital, Shizhong, Jinan 250001, P.R. China.
Yanhua XuDepartment of Gynaecology and Obstetrics, Jinan Maternity and Child Care Hospital, Shizhong, Jinan 250001, P.R. China.
Xiaoge HuangDepartment of Gynaecology and Obstetrics, Jinan Maternity and Child Care Hospital, Shizhong, Jinan 250001, P.R. China.
Jinan Maternity And Care Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adenomyosis is a pathological gynaecological condition characterized by benign invasion of the endometrium into the myometrium. High intensity focused ultrasound (HIFU) is one of the most common therapeutic strategies for the treatment of adenomyosis. However, the efficacy of single HIFU therapy is insufficient for the treatment of patients with adenomyosis. In the present study, the efficacy of HIFU and metformin for the treatment of adenomyosis was analyzed in 274 patients with adenomyosis who were admitted to Jinan Maternity and Child Care Hospital. The results demonstrated that there was a significant reduction in menstrual flow and pain between patients who received HIFU and metformin, and those who received single HIFU treatment (P<0.01). Furthermore, the outcomes demonstrated that inflammatory cytokines levels were significantly lower compared with the baseline values (P<0.01). In conclusion, the outcomes of the current study indicate that combined HIFU and metformin treatment is more efficacious in patients with enlarged adenomyosis compared with single HIFU treatment.

Indexed as

adenomyosishigh intensity focused ultrasoundinflammationmenstrual flowmetforminpain

Identifiers

PMID29434812
PMCPMC5776654
OpenAlexW2773305494

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.